Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

- Episodic Migraine Headache
- Completed

Study Title: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Teva Identifier: LBR-101-022

ClinicalTrials.gov Identifier: NCT02025556

Study Status: Completed

Trial Condition(s): Episodic Migraine Headache

Interventions: Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 65 Years

Trial Duration: 01/01/2014 - 03/01/2015

Phase: Phase 2

Study Type

Interventional